治咳川贝枇杷滴丸对慢性阻塞性肺病急性加重期患者的疗效观察

目的 观察治咳川贝枇杷滴丸对慢性阻塞性肺病急性加重期患者的疗效。方法 将60例慢性阻塞性肺病急性加重期患者随机分为治疗组与对照组各30例，对照组给予规范化常规治疗，治疗组患者在对照组治疗基础上再给予治咳川贝枇杷滴丸，口服或舌下含服，6粒/次，3次/d，10 d为一疗程，治疗结束后观察治疗疗效。结果 治疗后两组患者血气指标及CAT评分均优于入院时；且治疗组与对照组相比改善更明显（P＜0.05）；治疗组起效时间与对照组相比更短；对照组与治疗组显效率分别为73.3%、80%，两者差异具有统计学意义（P＜0.05）。结论 在常规治疗基础上应用治咳川贝枇杷滴丸对慢性阻塞性肺病急性加重期患者血气分析及临床症状改善更明显，起效时间更短，显效率更明显；能够更快、更好地缓解慢性阻塞性肺病急性加重期患者的症状。

Clinical observation of Zhike Chuanbei Pipa Dropping Pill on acute exacerbation of chronic obstructive pulmonary disease

Objective To observe the clinical efficacy of Zhike Chuanbei Pipa Dropping Pill (ZCPDP) on acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods A total of 60 patients with acute exacerbation of COPD were randomly divided into treatment (30 cases) and control (30 cases) groups. The patients in the control group were treated with standardized conventional treatment, and the patients in the treatment group were po or sublingually administered with ZCPDP In the control group, after treated as same as the treatment group the patients were administered with ZCPDP six pills once for three times daily, 10 d as one course. The therapeutic efficacy was evaluated in the end of the treatment. Results Indexes of blood gas analysis and CAT in two groups were all improved, especially in the treatment group (P < 0.05). The onset time of treatment group was shorter than that of control group. The significant efficiency of control and treatment groups was 73.3% and 80%, respectively, with the significant difference between the two groups (P < 0.05). Conclusion Combination with ZCPDP on the basis of conventional treatment could improve the result of blood-Qi analysis and the clinical symptoms more obviously, the onset time is more shorter, and the significant efficiency is more remarkable. It could relieve the acute exacerbation of COPD faster and better.